NCT01003769 2020-06-16Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic LeukemiaMayo ClinicPhase 1/2 Terminated5 enrolled 7 charts
NCT00891072 2013-01-10Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 1 Completed36 enrolled
NCT00275431 2011-06-29Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell MalignanciesAscenta TherapeuticsPhase 2 Completed50 enrolled
NCT00286780 2010-08-13Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic LeukemiaAscenta TherapeuticsPhase 2 Completed19 enrolled